Equity

AOCI

Medtronic AOCI decreased by 1.3% to -$4.33B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 52.5%, from -$2.84B to -$4.33B. Over 4 years (FY 2021 to FY 2025), AOCI shows a downward trend with a 5.3% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2015
Last reportedQ4 2025

How to read this metric

Large negative values often reflect unfavorable currency movements or a decline in the market value of the company's investment portfolio.

Detailed definition

A component of equity that aggregates unrealized gains and losses that are excluded from net income. This typically incl...

Peer comparison

Multinational corporations with significant overseas operations and large cash portfolios are more sensitive to this metric than domestic-only firms.

Metric ID: aoci

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value-$3.21B-$3.04B-$2.88B-$2.27B-$1.94B-$2.36B-$3.19B-$3.50B-$3.67B-$3.38B-$3.46B-$3.32B-$3.41B-$3.25B-$2.84B-$4.28B-$4.60B-$4.28B-$4.33B
QoQ Change+5.2%+5.4%+21.3%+14.4%-21.8%-35.1%-9.7%-5.0%+8.1%-2.4%+4.1%-2.8%+4.7%+12.6%-50.9%-7.5%+7.1%-1.3%
YoY Change+39.6%+22.4%-10.8%-54.5%-89.5%-43.0%-8.5%+5.2%+7.2%+3.8%+17.9%-29.1%-35.0%-31.5%-52.5%
Range-$4.60B-$1.94B
CAGR+6.9%
Avg YoY Growth-17.2%
Median YoY Growth-10.8%

Frequently Asked Questions

What is Medtronic's aoci?
Medtronic (MDT) reported aoci of -$4.33B in Q4 2025.
How has Medtronic's aoci changed year-over-year?
Medtronic's aoci decreased by 52.5% year-over-year, from -$2.84B to -$4.33B.
What is the long-term trend for Medtronic's aoci?
Over 4 years (2021 to 2025), Medtronic's aoci has grown at a 5.3% compound annual growth rate (CAGR), from -$3.49B to -$4.28B.
What does aoci mean?
A bucket for 'paper' gains or losses on investments and currency changes that haven't been finalized yet.